S&P 500
7,666.60
+35.13
+0.46%
Dow
53,061.95
+295.05
+0.56%
Nasdaq
26,217.83
+118.06
+0.45%
NYSE Composite
24,495.55
+146.25
+0.60%
Russell 2000
2,953.17
+33.04
+1.13%
VIX
15.37
+0.17
+1.12%
CL · Colgate-Palmolive Company
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Colgate-Palmolive Co (CL)
NEW YORK STOCK EXCHANGE, INC.
Consumer products
$90.14
+0.50
(+0.56%)
● At close: September 2 at 4:00:00 PM EDT
$90.66
+0.56
(+0.62%)
Pre-Market:
8:10:49 AM EDT
DAY'S RANGE
$90.14
$89.59
$90.97
52-WEEK RANGE
$90.14
$74.55
$99.33
What's happening
- CL is up 0.56% today, trading at $90.14. — Live quote
- Volume today (129,502) is well below its 3-month average of 4,935,060. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $0.99 actual vs. $0.98 estimated (+1.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 15
Hold 10
Sell 0
Strong sell 1
Aggregate ratings for 2026-09-01 (31 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CL
+14.02%
vs S&P 500
+1.82%
1-YEAR RETURN
CL
+7.51%
vs S&P 500
-11.36%
6-MONTH RETURN
CL
-9.12%
3-MONTH RETURN
CL
+2.07%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.99
Est. $0.98
BEAT +1.5%
2026-04-26 (Q1 2026)
$0.97
Est. $0.97
MISS -0.3%
2026-01-26 (Q4 2025)
$0.95
Est. $0.94
BEAT +1.1%
2025-10-26 (Q3 2025)
$0.91
Est. $0.92
MISS -0.5%
Valuation Measures & Ratios
Enterprise Value4$80.82B
Forward P/E523.24
PEG Ratio67.29
Price / Sales (TTM1)3.53
Price / Book7310.85
EV4 / Revenue3.84
EV4 / EBITDA21.36
Profit Margin9.68%
Operating Margin14.93%
Return on Equity (ROE8)631.14%
Return on Assets (ROA9)12.12%
Avg Volume (3M)4,935,060
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $73.43B | $67.99B | $62.99B | $71.96B | $73.35B |
| P/E | 26.07 | 24.16 | 21.68 | 24.80 | 25.82 |
| Price/Sales | 3.51 | 3.32 | 3.12 | 3.58 | 3.66 |
| Price/Book | 311.13 | 468.91 | 73.59 | 102.50 | 202.07 |
| EV/Revenue | 3.82 | 3.64 | 3.42 | 3.87 | 4.01 |
| EV/EBITDA | 16.86 | 15.57 | 14.12 | — | — |
| ROE | 1193.64% | 1940.69% | 339.37% | 413.25% | 782.64% |
| ROA | 16.78% | 16.94% | 16.59% | 16.61% | 17.07% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short17,557,432
Change from Prior Settlement-1.18%
% of Float—
Days to Cover (Short Ratio)4.04
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Loading chart…
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 4.9% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +7.5%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 9.7%. Finnhub fundamentals ↗
- Trailing P/E is 36.5, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-26; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.36B | $5.32B | $5.13B | $5.11B | $4.91B | $5.03B | $5.06B | $5.07B |
| Gross profit | $3.30B | $3.23B | $3.05B | $3.07B | $2.99B | $3.07B | $3.07B | $3.04B |
| Operating income | $1.02B | $964.0M | $1.06B | $1.08B | $1.08B | $1.06B | $1.09B | $1.05B |
| Net income | $693.0M | $646.0M | $735.0M | $743.0M | $690.0M | $737.0M | $731.0M | $683.0M |
| EPS (diluted) | $0.86 | $0.80 | $0.91 | $0.91 | $0.85 | $0.90 | $0.89 | $0.83 |
| EPS (basic) | $0.87 | $0.81 | $0.91 | $0.92 | $0.85 | $0.90 | $0.89 | $0.83 |
| Operating margin | $19 | $18 | $21 | $21 | $22 | $21 | $22 | $21 |
| Net margin | $13 | $12 | $14 | $15 | $14 | $15 | $14 | $13 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $16.79B | $16.61B | $16.33B | $17.51B | $17.47B | $16.65B | $16.05B | $16.77B |
| Total liabilities | $16.22B | $16.12B | $15.96B | $16.27B | $16.42B | $15.91B | $15.50B | $15.94B |
| Stockholders' equity | $236.0M | $145.0M | $54.0M | $856.0M | $702.0M | $363.0M | $212.0M | $435.0M |
| Total current assets | $6.31B | $6.08B | $5.71B | $6.04B | $6.00B | $5.81B | $5.32B | $5.81B |
| Total current liabilities | $6.15B | $5.93B | $6.85B | $6.50B | $6.78B | $6.86B | $5.76B | $5.57B |
| Cash & equivalents | $1.37B | $1.33B | $1.29B | $1.28B | $1.22B | $1.11B | $1.10B | $1.23B |
| Marketable securities (current) | — | — | $107.0M | — | — | — | $160.0M | — |
| Accounts receivable | $1.96B | $1.89B | $1.68B | $1.81B | $1.77B | $1.73B | $1.52B | $1.71B |
| Inventory | $2.18B | $2.09B | $2.03B | $2.11B | $2.12B | $2.12B | $1.99B | $2.04B |
| Other current assets | $795.0M | $772.0M | $714.0M | $844.0M | $888.0M | $852.0M | $713.0M | $819.0M |
| Property, plant & equipment | $4.64B | $4.62B | $4.66B | $4.56B | $4.53B | $4.42B | $4.42B | $4.42B |
| Goodwill | $3.10B | $3.11B | $3.12B | $3.70B | $3.70B | $3.33B | $3.27B | $3.39B |
| Intangible assets | $1.50B | $1.52B | $1.54B | $1.89B | $1.90B | $1.78B | $1.76B | $1.83B |
| Other non-current assets | $1.03B | $1.07B | $1.10B | $1.11B | $1.13B | $1.09B | $1.08B | $1.10B |
| Accounts payable | $2.12B | $2.10B | $2.09B | $1.87B | $1.79B | $1.80B | $1.80B | $1.62B |
| Short-term debt | — | — | $1.11B | — | — | $1.70B | $652.0M | $20.0M |
| Long-term debt | $7.82B | $7.94B | $6.87B | $7.31B | $7.14B | $6.57B | $7.29B | $7.91B |
| Other non-current liabilities | $2.05B | $2.06B | $2.06B | $2.17B | $2.22B | $2.18B | $2.11B | $2.14B |
| Common stock & paid-in capital | $1.47B | $1.47B | $1.47B | $1.47B | $1.47B | $1.47B | $1.47B | $1.47B |
| Retained earnings | $27.09B | $26.82B | $26.59B | $27.05B | $26.73B | $26.41B | $26.14B | $25.81B |
| Accumulated other comprehensive income (loss) | -$3.82B | -$3.87B | -$3.88B | -$3.89B | -$3.92B | -$4.12B | -$4.22B | -$4.07B |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $995.0M | $747.0M | $1.45B | $1.26B | $884.0M | $600.0M | $1.27B | $1.17B |
| Investing cash flow | -$122.0M | -$122.0M | -$103.0M | -$154.0M | -$401.0M | -$159.0M | -$80.0M | -$150.0M |
| Financing cash flow | -$851.0M | -$563.0M | -$1.36B | -$1.03B | -$409.0M | -$458.0M | -$1.28B | -$904.0M |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | $155.0M | $156.0M | $482.0M | $158.0M | $151.0M | $148.0M | $455.0M | $150.0M |
| Share-based compensation | $38.0M | $40.0M | $28.0M | $72.0M | $32.0M | $23.0M | $27.0M | $65.0M |
| Deferred income taxes | — | — | -$156.0M | — | — | — | -$33.0M | — |
| Change in inventory | $69.0M | $41.0M | -$100.0M | -$6.0M | -$89.0M | $86.0M | $6.0M | $77.0M |
| Purchases of investments | $54.0M | $70.0M | $161.0M | $153.0M | $250.0M | $134.0M | $216.0M | $115.0M |
| Other investing activities | -$4.0M | $8.0M | $9.0M | $4.0M | $3.0M | -$2.0M | -$16.0M | -$17.0M |
| Share repurchases | $291.0M | $306.0M | $406.0M | $288.0M | $232.0M | $284.0M | $455.0M | $295.0M |
| Other financing activities | -$20.0M | -$23.0M | -$13.0M | $9.0M | $104.0M | $32.0M | -$92.0M | $44.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B |
| EPS (diluted) | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 |
| EPS (basic) | $2.64 | $3.53 | $2.78 | $2.13 | $2.56 |
| Operating margin | $16 | $21 | $20 | $16 | $19 |
| Net margin | $10 | $14 | $12 | $10 | $12 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.93B | $14.07B |
| Stockholders' equity | $54.0M | $212.0M | $609.0M | $401.0M | $609.0M |
| Total current assets | $5.71B | $5.32B | $5.28B | $5.11B | $4.40B |
| Total current liabilities | $6.85B | $5.76B | $4.74B | $4.00B | $4.05B |
| Cash & equivalents | $1.29B | $1.10B | $966.0M | $775.0M | $832.0M |
| Marketable securities (current) | $107.0M | $160.0M | $179.0M | — | — |
| Accounts receivable | $1.68B | $1.52B | $1.59B | $1.50B | $1.30B |
| Inventory | $2.03B | $1.99B | $1.93B | $2.07B | $1.69B |
| Other current assets | $714.0M | $713.0M | $793.0M | $760.0M | $576.0M |
| Property, plant & equipment | $4.66B | $4.42B | $4.58B | $4.31B | $3.73B |
| Goodwill | $3.12B | $3.27B | $3.41B | $3.35B | $3.28B |
| Intangible assets | $1.54B | $1.76B | $1.89B | $1.92B | $2.46B |
| Other non-current assets | $1.10B | $1.08B | $1.02B | $904.0M | $974.0M |
| Accounts payable | $2.09B | $1.80B | $1.70B | $1.55B | $1.48B |
| Short-term debt | $1.11B | $652.0M | $20.0M | $14.0M | $12.0M |
| Long-term debt | $6.87B | $7.29B | $8.22B | $8.74B | $7.19B |
| Other non-current liabilities | $2.06B | $2.11B | $2.12B | $1.80B | $2.43B |
| Common stock & paid-in capital | $1.47B | $1.47B | $1.47B | $1.47B | $1.47B |
| Retained earnings | $26.59B | $26.14B | $25.29B | $24.57B | $24.35B |
| Accumulated other comprehensive income (loss) | -$3.88B | -$4.22B | -$3.94B | -$4.05B | -$4.39B |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $4.20B | $4.11B | $3.75B | $2.56B | $3.33B |
| Investing cash flow | -$817.0M | -$534.0M | -$742.0M | -$1.60B | -$592.0M |
| Financing cash flow | -$3.26B | -$3.39B | -$2.79B | -$952.0M | -$2.77B |
| Free cash flow | — | — | — | $1.86B | $2.76B |
| Capital expenditures | — | — | — | $696.0M | $567.0M |
| Depreciation & amortization | $630.0M | $605.0M | $567.0M | $545.0M | $556.0M |
| Share-based compensation | $155.0M | $135.0M | $122.0M | $125.0M | $135.0M |
| Deferred income taxes | -$156.0M | -$33.0M | -$135.0M | -$163.0M | -$37.0M |
| Change in inventory | -$109.0M | $100.0M | -$194.0M | $333.0M | $72.0M |
| Purchases of investments | $698.0M | $574.0M | $506.0M | $470.0M | $141.0M |
| Other investing activities | $14.0M | -$37.0M | $33.0M | -$5.0M | $25.0M |
| Share repurchases | $1.21B | $1.74B | $1.13B | $1.31B | $1.32B |
| Other financing activities | $132.0M | -$91.0M | $18.0M | -$18.0M | -$24.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers54.4%
Shares Outstanding799,400,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 69,915,472 | $6.41B | 8.75% | -3.8% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 52,246,333 | $4.79B | 6.54% | +0.1% | 2026-06-30 |
| State Street Corp | 47,020,966 | $4.31B | 5.88% | -1.5% | 2026-08-07 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 27,909,525 | $2.6M | 3.49% | -17.3% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 24,021,137 | $2.20B | 3.00% | +0.8% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 23,144,319 | $2.14B | 2.90% | +1.1% | 2026-08-12 |
| Morgan Stanley | 22,072,925 | $2.02B | 2.76% | +5.7% | 2026-08-11 |
| Bank of New York Mellon Corp | 13,532,417 | $1.24B | 1.69% | +8.1% | 2026-08-06 |
| DEUTSCHE BANK AG\ | 11,751,973 | $1.08B | 1.47% | -1.5% | 2026-08-07 |
| NORGES BANK | 9,686,029 | $888.0M | 1.21% | +0.0% | 2026-08-12 |
| ACADIAN ASSET MANAGEMENT LLC | 9,096,779 | $833.9K | 1.14% | +14.6% | 2026-08-12 |
| FMR LLC | 8,983,071 | $823.6M | 1.12% | -0.3% | 2026-08-13 |
| Goldman Sachs Group Inc | 8,571,015 | $785.8M | 1.07% | -9.5% | 2026-08-14 |
| Northern Trust Corp | 8,471,575 | $776.7M | 1.06% | -2.4% | 2026-08-12 |
| Invesco Ltd. | 8,325,612 | $763.3M | 1.04% | -0.2% | 2026-08-13 |
| First Eagle Investment Management, LLC | 8,205,699 | $752.3M | 1.03% | -49.5% | 2026-08-05 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 6,730,570 | $617.1M | 0.84% | +0.0% | 2026-07-28 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6,471,404 | $593.3M | 0.81% | -5.2% | 2026-08-13 |
| Amundi | 6,218,257 | $570.1M | 0.78% | +19.9% | 2026-08-11 |
| Bank Of America Corp /De/ | 6,189,824 | $567.5M | 0.77% | -6.7% | 2026-08-14 |
| Royal Bank Of Canada | 5,591,400 | $512.6M | 0.70% | +13.2% | 2026-08-13 |
| Legal & General Group Plc | 5,416,333 | $496.6M | 0.68% | -5.3% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 5,328,913 | $488.6M | 0.67% | +2.7% | 2026-08-11 |
| Ameriprise Financial Inc | 5,226,139 | $479.1M | 0.65% | +0.5% | 2026-08-14 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 5,148,163 | $472.0M | 0.64% | +0.5% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-23 to 2026-08-24
Recent transactions
- Insiders have net sold 347,111 shares over the last 182 days, across 0 purchases and 6 sales.
- Most recent: Tsourapas Panagiotis (COO, CD, EMEA, APac, Skin) — Open market sale of 10,000 shares on 2026-08-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)347,111 sh(6 txns)
Net Shares-347,111
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | Open market sale | 2026-08-24 | 10,000 |
| CAHILL JOHN T | Director | Option exercise | 2026-08-06 | 4,170 |
| Wallace Noel R. | Chairman, President & CEO | Option exercise | 2026-08-05 | 161,021 |
| NORRINGTON LORRIE M | Director | Grant / award | 2026-07-01 | 293 |
| Newman Brian | Director | Grant / award | 2026-07-01 | 209 |
| BILBREY JOHN P | Director | Grant / award | 2026-07-01 | 265 |
| GRANT SHANE | COO, Americas | Tax withholding | 2026-06-16 | 23,347 |
| Malcolm Gregory | EVP and Controller | Open market sale | 2026-05-15 | 2,300 |
| Nelson Kimberly A | Director | Grant / award | 2026-05-11 | 2,075 |
| HUNDMEJEAN MARTINA | Director | Grant / award | 2026-05-11 | 2,075 |
| HARRIS C MARTIN | Director | Grant / award | 2026-05-11 | 1,556 |
| Edwards Lisa | Director | Grant / award | 2026-05-11 | 2,075 |
| BOERNER CHRISTOPHER S. | Director | Grant / award | 2026-05-11 | 1,383 |
| Massey Sally | Chief People Officer | Open market sale | 2026-05-07 | 8,599 |
| Hazlin John | Chief Growth Officer | Grant / award | 2026-02-23 | 12,803 |
| Daniels Jennifer | CLO and Secretary | Grant / award | 2026-02-23 | 25,742 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-24 | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | Open market sale | 10,000 | $92.05 |
| 2026-08-06 | CAHILL JOHN T | Director | Option exercise | 4,170 | $71.56 |
| 2026-08-06 | CAHILL JOHN T | Director | Open market sale | 4,170 | $93.37 |
| 2026-08-05 | Wallace Noel R. | Chairman, President & CEO | Option exercise | 161,021 | $72.29 |
| 2026-08-05 | Wallace Noel R. | Chairman, President & CEO | Open market sale | 161,021 | $92.52 |
| 2026-08-04 | Wallace Noel R. | Chairman, President & CEO | Option exercise | 161,021 | $72.29 |
| 2026-08-04 | Wallace Noel R. | Chairman, President & CEO | Open market sale | 161,021 | $91.92 |
| 2026-07-01 | NORRINGTON LORRIE M | Director | Grant / award | 293 | $89.45 |
| 2026-07-01 | Newman Brian | Director | Grant / award | 209 | $89.45 |
| 2026-07-01 | BILBREY JOHN P | Director | Grant / award | 265 | $89.45 |
| 2026-06-16 | GRANT SHANE | COO, Americas | Tax withholding | 23,347 | $90.66 |
| 2026-05-15 | Malcolm Gregory | EVP and Controller | Open market sale | 2,300 | $88.44 |
| 2026-05-11 | Newman Brian | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-11 | Nelson Kimberly A | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-11 | HUNDMEJEAN MARTINA | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-11 | NORRINGTON LORRIE M | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-11 | HARRIS C MARTIN | Director | Grant / award | 1,556 | $0.00 |
| 2026-05-11 | Edwards Lisa | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-11 | CAHILL JOHN T | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-11 | BOERNER CHRISTOPHER S. | Director | Grant / award | 1,383 | $0.00 |
| 2026-05-11 | BILBREY JOHN P | Director | Grant / award | 2,075 | $0.00 |
| 2026-05-07 | Massey Sally | Chief People Officer | Open market sale | 8,599 | $87.41 |
| 2026-04-01 | NORRINGTON LORRIE M | Director | Grant / award | 294 | $89.05 |
| 2026-04-01 | Newman Brian | Director | Grant / award | 210 | $89.05 |
| 2026-04-01 | BILBREY JOHN P | Director | Grant / award | 266 | $89.05 |
| 2026-02-23 | Hazlin John | Chief Growth Officer | Grant / award | 12,803 | $0.00 |
| 2026-02-23 | Hazlin John | Chief Growth Officer | Tax withholding | 6,117 | $97.10 |
| 2026-02-23 | Daniels Jennifer | CLO and Secretary | Grant / award | 25,742 | $0.00 |
| 2026-02-23 | Daniels Jennifer | CLO and Secretary | Tax withholding | 12,351 | $97.10 |
| 2026-02-23 | Malcolm Gregory | EVP and Controller | Grant / award | 6,268 | $0.00 |
| 2026-02-23 | Malcolm Gregory | EVP and Controller | Tax withholding | 2,260 | $97.10 |
| 2026-02-23 | Massey Sally | Chief Human Resources Officer | Grant / award | 16,805 | $0.00 |
| 2026-02-23 | Massey Sally | Chief Human Resources Officer | Tax withholding | 8,206 | $97.10 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 12:29 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-07-31 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-31 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-05-18 | 4 | 2026-05-15 | View on SEC.gov → |
| 2026-05-13 | 4 | 2026-05-11 | View on SEC.gov → |
| 2026-05-13 | 4 | 2026-05-11 | View on SEC.gov → |
Recent news
Headlines about CL (Colgate-Palmolive Company). Links open the publisher — we don’t host full articles.
-
Oil pulls back, Broadcom disappoints - what’s moving markets
Yahoo · 2026-09-03 -
Dyson built a $499 toothbrush with a camera inside it
Yahoo · 2026-09-03 -
Colgate-Palmolive (CL) Draws Fresh Valuation Focus, Is The Stock Fully Priced?
Yahoo · 2026-09-02 -
3 Boring Stocks That Have Quietly Outlasted Every Bear Market of the Last 50 Years.
Yahoo · 2026-09-02 -
Colgate-Palmolive: Don't Ignore This Resilient Dividend King
SeekingAlpha · 2026-09-02 -
2 Dividend Kings, 1 Clear Winner: P&G vs. Colgate
Yahoo · 2026-09-02 -
U.S. policy shift on Venezuelan oil raises stakes for production and debt: BofA
Yahoo · 2026-09-02 -
Procter & Gamble Fabric & Home Care Trends Mixed: Is Growth Ahead?
Yahoo · 2026-09-02
No headlines in this category right now — try “All”.